(Q48228911)

9 February 2018

title

MRI evaluation of brain iron in earlier- and later-onset Parkinson's disease and normal subjects. (English)

1 reference

9 February 2018

magnetic resonance imaging

1 reference

0 references

author name string

Bartzokis G

1

1 reference

9 February 2018

Cummings JL

2

1 reference

9 February 2018

Markham CH

3

1 reference

9 February 2018

Marmarelis PZ

4

1 reference

9 February 2018

Treciokas LJ

5

1 reference

9 February 2018

Tishler TA

6

1 reference

9 February 2018

Marder SR

7

1 reference

9 February 2018

Mintz J

8

1 reference

9 February 2018

publication date

1 February 1999

1 reference

9 February 2018

Magnetic Resonance Imaging

published in

1 reference

9 February 2018

volume

17

1 reference

9 February 2018

issue

2

1 reference

9 February 2018

page(s)

213-222

1 reference

9 February 2018

Iron regulation in the brain: histochemical, biochemical, and molecular considerations

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0730-725X%2898%2900155-6

7 January 2021

Desferrioxamine and vitamin E protect against iron and MPTP-induced neurodegeneration in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0730-725X%2898%2900155-6

7 January 2021

The effect of age on the non-haemin iron in the human brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0730-725X%2898%2900155-6

7 January 2021

Studies on Parkinson's Disease Including X-Ray Fluorescent Spectroscopy of Formalin Fixed Brain Tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0730-725X%2898%2900155-6

7 January 2021

Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain

1 reference

https://api.crossref.org/works/10.1016%2FS0730-725X%2898%2900155-6

7 January 2021

Brain iron and ferritin in Parkinson's and Alzheimer's diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0730-725X%2898%2900155-6

7 January 2021

Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia

1 reference

https://api.crossref.org/works/10.1016%2FS0730-725X%2898%2900155-6

7 January 2021

Complex I, iron, and ferritin in Parkinson's disease substantia nigra

1 reference

https://api.crossref.org/works/10.1016%2FS0730-725X%2898%2900155-6

7 January 2021

Iron and aluminum increase in the substantia nigra of patients with Parkinson's disease: an X-ray microanalysis

1 reference

https://api.crossref.org/works/10.1016%2FS0730-725X%2898%2900155-6

7 January 2021

Selective Increase of Iron in Substantia Nigra Zona Compacta of Parkinsonian Brains

1 reference

https://api.crossref.org/works/10.1016%2FS0730-725X%2898%2900155-6

7 January 2021

Transition Metals, Ferritin, Glutathione, and Ascorbic Acid in Parkinsonian Brains

1 reference

https://api.crossref.org/works/10.1016%2FS0730-725X%2898%2900155-6

7 January 2021

Transferrin and iron in normal, Alzheimer's disease, and Parkinson's disease brain regions

1 reference

https://api.crossref.org/works/10.1016%2FS0730-725X%2898%2900155-6

7 January 2021

Brain iron homeostasis

1 reference

https://api.crossref.org/works/10.1016%2FS0730-725X%2898%2900155-6

7 January 2021

A quantitative analysis of isoferritins in select regions of aged, parkinsonian, and Alzheimer's diseased brains

1 reference

https://api.crossref.org/works/10.1016%2FS0730-725X%2898%2900155-6

7 January 2021

T2 values in the human brain: comparison with quantitative assays of iron and ferritin

1 reference

https://api.crossref.org/works/10.1016%2FS0730-725X%2898%2900155-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0730-725X%2898%2900155-6

1 reference

7 January 2021

Magnetic resonance imaging evidence of decreased putamenal iron content in idiopathic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0730-725X%2898%2900155-6

7 January 2021

T2 relaxation time in patients with Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0730-725X%2898%2900155-6

7 January 2021

Increased iron-related MRI contrast in the substantia nigra in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0730-725X%2898%2900155-6

7 January 2021

Field dependent transverse relaxation rate increase may be a specific measure of tissue iron stores.

1 reference

https://api.crossref.org/works/10.1016%2FS0730-725X%2898%2900155-6

7 January 2021

In vivo evaluation of brain iron in Alzheimer's disease and normal subjects using MRI.

1 reference

https://api.crossref.org/works/10.1016%2FS0730-725X%2898%2900155-6

7 January 2021

MR evaluation of age-related increase of brain iron in young adult and older normal males

1 reference

https://api.crossref.org/works/10.1016%2FS0730-725X%2898%2900155-6

7 January 2021

The quantitative relation between T1-weighted and T2-weighted MRI of normal gray matter and iron concentration

1 reference

https://api.crossref.org/works/10.1016%2FS0730-725X%2898%2900155-6

7 January 2021

The relation between brain iron and NMR relaxation times: an in vitro study

1 reference

https://api.crossref.org/works/10.1016%2FS0730-725X%2898%2900155-6

7 January 2021

T1 and T2 of ferritin solutions: effect of loading factor

1 reference

https://api.crossref.org/works/10.1016%2FS0730-725X%2898%2900155-6

7 January 2021

Magnetic resonance imaging of brain iron in health and disease

1 reference

https://api.crossref.org/works/10.1016%2FS0730-725X%2898%2900155-6

7 January 2021

Hepatic hemosiderosis in non-human primates: quantification of liver iron using different field strengths

1 reference

https://api.crossref.org/works/10.1016%2FS0730-725X%2898%2900155-6

7 January 2021

Risk factors on the occurrence of response fluctuations and dyskinesias in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0730-725X%2898%2900155-6

7 January 2021

Early development of levodopa-induced dyskinesias and response fluctuations in young-onset Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0730-725X%2898%2900155-6

7 January 2021

Young-onset Parkinson's disease: a clinical review

1 reference

https://api.crossref.org/works/10.1016%2FS0730-725X%2898%2900155-6

7 January 2021

Old-onset Parkinson's disease compared with young-onset disease: clinical differences and similarities

1 reference

https://api.crossref.org/works/10.1016%2FS0730-725X%2898%2900155-6

7 January 2021

Effect of age at onset on frequency of depression in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0730-725X%2898%2900155-6

7 January 2021

The frequency of idiopathic Parkinson's disease by age, ethnic group, and sex in northern Manhattan, 1988-1993

1 reference

https://api.crossref.org/works/10.1016%2FS0730-725X%2898%2900155-6

7 January 2021

Epidemiology of Parkinson's disease in Finland

1 reference

https://api.crossref.org/works/10.1016%2FS0730-725X%2898%2900155-6

7 January 2021

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0730-725X%2898%2900155-6

7 January 2021

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0730-725X%2898%2900155-6

7 January 2021

PD and the Columbia Scale

1 reference

https://api.crossref.org/works/10.1016%2FS0730-725X%2898%2900155-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0730-725X%2898%2900155-6

1 reference

7 January 2021

Anterior commissure: anatomic-MR correlation and use as a landmark in three orthogonal planes.

1 reference

https://api.crossref.org/works/10.1016%2FS0730-725X%2898%2900155-6

7 January 2021

Histochemical distribution of non-haem iron in the human brain

1 reference

https://api.crossref.org/works/10.1016%2FS0730-725X%2898%2900155-6

7 January 2021

Does signal-attenuation on high-field T2-weighted MRI of the brain reflect regional cerebral iron deposition? Observations on the relationship between regional cerebral water proton T2 values and iron levels

1 reference

https://api.crossref.org/works/10.1016%2FS0730-725X%2898%2900155-6

7 January 2021

Basal ganglia: significance of signal hypointensity on T2-weighted MR images

1 reference

https://api.crossref.org/works/10.1016%2FS0730-725X%2898%2900155-6

7 January 2021

MR microscopy at 7.0 T: Effects of brain iron

1 reference

https://api.crossref.org/works/10.1016%2FS0730-725X%2898%2900155-6

7 January 2021

Age distribution and iron dependency of the T2 relaxation time in the globus pallidus and putamen.

1 reference

https://api.crossref.org/works/10.1016%2FS0730-725X%2898%2900155-6

7 January 2021

Nuclear magnetic resonance relaxation in experimental brain edema: effects of water concentration, protein concentration, and temperature

1 reference

https://api.crossref.org/works/10.1016%2FS0730-725X%2898%2900155-6

7 January 2021

Ageing and Parkinson's disease: substantia nigra regional selectivity

1 reference

https://api.crossref.org/works/10.1016%2FS0730-725X%2898%2900155-6

7 January 2021

T2 estimates in healthy and diseased brain tissue: a comparison using various MR pulse sequences.

1 reference

https://api.crossref.org/works/10.1016%2FS0730-725X%2898%2900155-6

7 January 2021

Prevalence of parkinsonism and Parkinson's disease in Europe: the EUROPARKINSON Collaborative Study. European Community Concerted Action on the Epidemiology of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0730-725X%2898%2900155-6

7 January 2021

The importance of free radicals and catalytic metal ions in human diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0730-725X%2898%2900155-6

7 January 2021

10.1016/S0730-725X(98)00155-6

Identifiers

DOI

1 reference

9 February 2018

PubMed ID

10215476

1 reference

9 February 2018